Top research on diabetes care, management from ADA 2016

Researchers presented data and clinical updates at the American Diabetes Association Scientific Sessions.

Coverage from the Endocrine Today team featured news from the conference and research implications on patient care and practice. Healio Internal Medicine presents the latest updates in in diabetes from the meeting.

Overnight closed-loop system improves time in target range, reduces hypoglycemic episodes

An overnight closed-loop insulin-delivery system was beneficial for improving time in target range overnight for adults and reducing nocturnal hypoglycemia in adolescents, according to results. Read more.

iGlarLixi combination injection reduces HbA1c, body weight

Adults with poorly controlled type 2 diabetes assigned a combination insulin glargine and lixisenatide injection saw greater glycemic control, modest weight loss and no additional hypoglycemia risk vs. patients assigned insulin glargine alone, according to data. Read more.

HEPLISAV-B vaccine safe, effective against HBV in patients with type 2 diabetes

Adults with type 2 diabetes, who are more susceptible to hepatitis B virus infection than individuals without diabetes, had significantly higher rates of protection against the virus after receiving two doses of the investigational HEPLISAV-B vaccine compared with three doses of a currently licensed vaccine with a similar safety profile, according to preliminary results. Read more.

Computerized IV insulin administration improves blood glucose control

Inpatient blood glucose was controlled and hypoglycemia was minimized with the use of a computerized IV insulin administration, according to a presenter. Read more.

Estimated HbA1c similar with continuous subcutaneous insulin infusion, multiple daily injections

Subcutaneous insulin infusion and multiple daily injections using a continuous glucose monitor both yielded similar estimated HbA1c levels, according to data. Read more.

Insulin-only, bihormonal bionic pancreas comparable to insulin pump therapy

When compared with a bihormonal bionic pancreas, an insulin-only bionic pancreas yielded similar results for blood glucose control, and no differences were found for hypoglycemic episodes, according to a presenter. Read more.

Service dogs can detect hypoglycemia, alert companion

Service dogs trained to identify hypoglycemia in their human companions can correctly identify the condition and sound a timely alert, according to study findings. Read more.

Bionic pancreas effective in home setting for reducing glucose, hypoglycemia

Use of a bionic pancreas was associated with reductions in mean glucose and hypoglycemia compared with conventional insulin pump therapy, when used in the home setting by adults with type 1 diabetes. Read more.

Health-related quality of life ‘neglected offspring’ in comprehensive diabetes care

Validated quality of life measures need to be incorporated into mainstream diabetes care and equated with the same level of importance as behavior change or HbA1c level, according to a speaker. Read more.